NYSE ORDER IMBALANCE 263852.0 SHARES ON BUY SIDE
15/07/2022 20:50
NYSE ORDER IMBALANCE ADCT.N 263852.0 SHARES ON BUY SIDE
Recent news on ADC Therapeutics SA
See all newsADC Therapeutics plunges after patient deaths in blood cancer drug trial
ADC Therapeutics falls on higher rates of serious side-effects in cancer trial
Switzerland's ADC Therapeutics beats Q1 revenue estimates
Switzerland's ADC Therapeutics posts smaller‑than‑expected Q4 net loss on lower R&D spend
Brief: ADC Therapeutics Q4 Income From Operations USD -17.919 Million Vs. IBES Estimate USD -30.1 Million